Stay updated with breaking news from Presentation Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investigators will present study highlighting a phosphoproteomic diagnostic for patient stratification of first line systemic hepatocellular carcinoma therapy LONDON, May 28, 2024 /PRNewswire/
STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May
/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,...
Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA is a safe treatment option for advanced cancer patients.Encouraging VAXI...
– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired...